United States - English - NLM (National Library of Medicine)

akorn - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg - ethosuximide is indicated for the control of absence (petit mal) epilepsy.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide oral solution is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

versapharm incorporated - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

pai holdings, llc - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

greenstone llc - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

greenstone llc - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg - ethosuximide is indicated for the control of absence (petit mal) epilepsy.

United States - English - NLM (National Library of Medicine)

mikart, llc - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg in 5 ml - ethosuximide is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 - ethosuximide capsule is indicated for the control of absence (petit mal) epilepsy. ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

United States - English - NLM (National Library of Medicine)

banner life sciences llc. - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg - ethosuximide is indicated for the control of absence (petit mal) epilepsy.

United States - English - NLM (National Library of Medicine)

bionpharma inc. - ethosuximide (unii: 5seh9x1d1d) (ethosuximide - unii:5seh9x1d1d) - ethosuximide 250 mg - ethosuximide capsules are indicated for the control of absence (petit mal) epilepsy.